• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    8/16/23 1:31:36 PM ET
    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $CBIO alert in real time by email

    Gainers

    • Novo Integrated Sciences (NASDAQ:NVOS) stock increased by 68.6% to $0.2 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 346.2 million, which is 3787.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.0 million.
    • Tivic Health Systems (NASDAQ:TIVC) stock increased by 59.13% to $0.06. As of 13:31 EST, this security is trading at a volume of 226.3 million shares, making up 1191.2% of its average full-day volume over the last 100 days. The company's market cap stands at $8.6 million. The company's, Q2 earnings came out 2 days ago.
    • Navidea Biopharmaceutical (AMEX:NAVB) stock increased by 27.93% to $0.09. Trading volume for Navidea Biopharmaceutical's stock is 16.3 million as of 13:31 EST. This is 213.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.9 million.
    • Miromatrix Medical (NASDAQ:MIRO) stock rose 18.96% to $1.53. The current volume of 63.0K shares is 116.6% of Miromatrix Medical's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $41.6 million. As per the press release, Q2 earnings came out 2 days ago.
    • Catalyst Biosciences (NASDAQ:CBIO) shares moved upwards by 16.21% to $0.43. As of 13:31 EST, Catalyst Biosciences's stock is trading at a volume of 835.3K, which is 152.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
    • Star Equity Hldgs (NASDAQ:STRR) stock rose 13.84% to $0.94. As of 13:31 EST, Star Equity Hldgs's stock is trading at a volume of 399.3K, which is 264.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.3 million. The company's, Q2 earnings came out 3 days ago.

    Losers

    • Impel Pharmaceuticals (NASDAQ:IMPL) stock decreased by 43.6% to $0.61 during Wednesday's regular session. Trading volume for Impel Pharmaceuticals's stock is 730.1K as of 13:31 EST. This is 106.6% of its average full-day volume over the last 100 days. The company's market cap stands at $14.4 million.
    • RVL Pharmaceuticals (NASDAQ:RVLP) shares declined by 41.67% to $0.24. Trading volume for RVL Pharmaceuticals's stock is 1.4 million as of 13:31 EST. This is 1601.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.3 million. The company's, Q2 earnings came out 2 days ago.
    • Mallinckrodt (AMEX:MNK) stock declined by 23.81% to $0.56. As of 13:31 EST, Mallinckrodt's stock is trading at a volume of 834.9K, which is 17.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.4 million.
    • Rockwell Medical (NASDAQ:RMTI) shares fell 21.38% to $2.17. Trading volume for this security as of 13:31 EST is 1.6 million, which is 142.3% of its average full-day volume over the last 100 days. The company's market cap stands at $61.8 million. As per the news, the Q2 earnings report came out 2 days ago.
    • G Medical Innovations (NASDAQ:GMVD) shares declined by 17.95% to $0.18. Trading volume for G Medical Innovations's stock is 2.4 million as of 13:31 EST. This is 262.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.7 million.
    • PAVmed (NASDAQ:PAVM) shares fell 16.96% to $0.25. As of 13:31 EST, PAVmed's stock is trading at a volume of 1.4 million, which is 282.9% of its average full-day volume over the last 100 days. The company's market cap stands at $26.5 million. As per the press release, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CBIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBIO
    $GMVD
    $IMPL
    $MIRO

    CompanyDatePrice TargetRatingAnalyst
    Crescent Biopharma Inc.
    $CBIO
    1/28/2026$35.00Overweight
    Piper Sandler
    Crescent Biopharma Inc.
    $CBIO
    1/21/2026$35.00Buy
    Guggenheim
    Crescent Biopharma Inc.
    $CBIO
    8/25/2025$26.00Buy
    Jefferies
    Crescent Biopharma Inc.
    $CBIO
    8/11/2025$25.00Buy
    H.C. Wainwright
    Crescent Biopharma Inc.
    $CBIO
    7/14/2025$27.00Outperform
    Wedbush
    Crescent Biopharma Inc.
    $CBIO
    6/25/2025$28.00Buy
    Stifel
    Rockwell Medical Inc.
    $RMTI
    11/14/2024$5.00Buy
    Rodman & Renshaw
    RVL Pharmaceuticals plc
    $RVLP
    10/21/2022$2.50Hold
    Jefferies
    More analyst ratings

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Diamond Matthew K

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    3/23/26 8:44:03 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    SEC Form 4 filed by Eberwein Jeffrey E.

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    3/23/26 8:43:17 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    SEC Form 4 filed by Wolf Lisa G

    4 - Tivic Health Systems, Inc. (0001787740) (Issuer)

    3/19/26 9:14:41 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Crescent Biopharma with a new price target

    Piper Sandler initiated coverage of Crescent Biopharma with a rating of Overweight and set a new price target of $35.00

    1/28/26 7:10:21 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Crescent Biopharma with a new price target

    Guggenheim initiated coverage of Crescent Biopharma with a rating of Buy and set a new price target of $35.00

    1/21/26 8:54:45 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Jefferies initiated coverage on Crescent Biopharma with a new price target

    Jefferies initiated coverage of Crescent Biopharma with a rating of Buy and set a new price target of $26.00

    8/25/25 8:12:09 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results

    OLD GREENWICH, Conn., March 17, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR) ("Star" or the "Company"), a diversified holding company, announced today financial results for the fourth quarter and full year ended December 31, 2025. 2025 Fourth Quarter Summary Revenue of $56.8 million increased 69% from the fourth quarter of 2024.Gross profit of $24.2 million increased 38% from the fourth quarter of 2024.Net loss attributable to common shareholders of $2.4 million, or $0.67 loss per diluted share, versus net loss attributable to common shareholders of $0.6 million, or $0.20 loss per diluted share, in the fourth quarter of 2024. Adjusted net loss attributable to common

    3/17/26 4:50:00 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

    Conference Call and Webcast at 8:30 AM ETNEW YORK, March 16, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Monday, March 30, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's fourth quarter 2025 financial r

    3/16/26 9:01:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    Star Equity Holdings to Release Fourth Quarter 2025 Financial Results on March 17

    OLD GREENWICH, Conn., March 13, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR) ("Star" or the "Company"), formerly Hudson Global, Inc. (NASDAQ:HSON), a diversified holding company, announced today that it will release its financial results for the fourth quarter ended December 31, 2025, after the close of the market on Tuesday, March 17, 2026. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on March 18, 2026, to discuss the results and management's outlook. The call may be accessed by dialing: Toll Free: 1-833-890-6161International: 1-412-504-9848 A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Inv

    3/13/26 5:40:00 PM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Eberwein Jeffrey E. sold $39,794 worth of Series A Preferred Stock (4,365 units at $9.12) and bought $81,503 worth of shares (7,268 units at $11.21), increasing direct ownership by 27% to 1,007,824 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/31/25 5:02:24 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. sold $173,974 worth of Series A Preferred Stock (18,635 units at $9.34) and bought $109,212 worth of shares (9,709 units at $11.25), increasing direct ownership by 23% to 1,000,556 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/29/25 7:09:34 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. bought $2,999,991 worth of shares (287,631 units at $10.43) and sold $2,999,994 worth of Series A Preferred Stock (320,855 units at $9.35), increasing direct ownership by 15% to 810,217 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/10/25 4:01:17 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    SEC Filings

    View All

    Star Equity Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Star Equity Holdings, Inc. (0001210708) (Filer)

    3/25/26 5:26:40 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Tivic Health Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    3/25/26 4:25:57 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form S-3 filed by Star Equity Holdings Inc.

    S-3 - Star Equity Holdings, Inc. (0001210708) (Filer)

    3/23/26 9:33:23 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TRUDHESA issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug TRUDHESA (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/13/21 2:21:35 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DIHYDROERGOTAMINE MESYLATE issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug DIHYDROERGOTAMINE MESYLATE (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/7/21 1:04:43 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Leadership Updates

    Live Leadership Updates

    View All

    Rockwell Medical Appoints Joe Dawson to the Company's Board of Directors

    Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company appointed Joe Dawson to its board of directors. Additionally, Andrea Heslin Smiley has resigned from the Company's board of directors to pursue other endeavors. "We are pleased to welcome Joe to Rockwell Medical's board of directors. Joe is a seasoned executive who has extensive operational experience, a strong network in the renal care space, and deep domain expertise in building and scaling commercial organizations," said Robert S. Radie, Chairman of t

    11/18/25 6:00:00 AM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rockwell Medical Names Rashad Brown Vice President, Manufacturing and Supply Chain

    Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Rashad Brown has joined the Company as Vice President, Manufacturing and Supply Chain. Mr. Brown brings more than two decades of leadership experience in manufacturing operations, procurement, warehouse management, and supply chain optimization within regulated healthcare manufacturing environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111461038/en/Rashad Brown - Vice President, Manufacturing

    11/11/25 6:00:00 AM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

    Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global conversation on Bioelectronic Medicine. She will join other leaders in the field to discuss the opportunities for advancing bioelectronic medicine. When: Thursday, Oct. 23, at 11:55 a.m. ET/8:55 a.m. PT Panel Title: Building a Big Tent Bioelectronic Medicine stands to disrupt how we diagnose, treat, and manage disease, but fulfilling that promise requires broad alignment across the healthcare ecosystem. This session will explore how to rally the global community,

    10/22/25 2:00:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Financials

    Live finance-specific insights

    View All

    Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results

    OLD GREENWICH, Conn., March 17, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR) ("Star" or the "Company"), a diversified holding company, announced today financial results for the fourth quarter and full year ended December 31, 2025. 2025 Fourth Quarter Summary Revenue of $56.8 million increased 69% from the fourth quarter of 2024.Gross profit of $24.2 million increased 38% from the fourth quarter of 2024.Net loss attributable to common shareholders of $2.4 million, or $0.67 loss per diluted share, versus net loss attributable to common shareholders of $0.6 million, or $0.20 loss per diluted share, in the fourth quarter of 2024. Adjusted net loss attributable to common

    3/17/26 4:50:00 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

    Conference Call and Webcast at 8:30 AM ETNEW YORK, March 16, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Monday, March 30, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's fourth quarter 2025 financial r

    3/16/26 9:01:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    Star Equity Holdings to Release Fourth Quarter 2025 Financial Results on March 17

    OLD GREENWICH, Conn., March 13, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR) ("Star" or the "Company"), formerly Hudson Global, Inc. (NASDAQ:HSON), a diversified holding company, announced today that it will release its financial results for the fourth quarter ended December 31, 2025, after the close of the market on Tuesday, March 17, 2026. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on March 18, 2026, to discuss the results and management's outlook. The call may be accessed by dialing: Toll Free: 1-833-890-6161International: 1-412-504-9848 A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Inv

    3/13/26 5:40:00 PM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary

    $CBIO
    $GMVD
    $IMPL
    $MIRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Rockwell Medical Inc.

    SC 13G/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)

    11/14/24 5:17:40 PM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by PAVmed Inc.

    SC 13G - PAVmed Inc. (0001624326) (Subject)

    11/14/24 10:02:46 AM ET
    $PAVM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by PAVmed Inc.

    SC 13G - PAVmed Inc. (0001624326) (Subject)

    9/23/24 8:46:15 PM ET
    $PAVM
    Medical/Dental Instruments
    Health Care